Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Euro Surveill ; 28(39)2023 09.
Article in English | MEDLINE | ID: mdl-37768558

ABSTRACT

Enteroviruses are a common cause of seasonal childhood infections. The vast majority of enterovirus infections are mild and self-limiting, although neonates can sometimes develop severe disease. Myocarditis is a rare complication of enterovirus infection. Between June 2022 and April 2023, twenty cases of severe neonatal enteroviral myocarditis caused by coxsackie B viruses were reported in the United Kingdom. Sixteen required critical care support and two died. Enterovirus PCR on whole blood was the most sensitive diagnostic test. We describe the initial public health investigation into this cluster and aim to raise awareness among paediatricians, laboratories and public health specialists.


Subject(s)
Enterovirus Infections , Enterovirus , Myocarditis , Infant, Newborn , Humans , Child , Myocarditis/diagnosis , Myocarditis/complications , Enterovirus Infections/complications , Enterovirus Infections/diagnosis , Enterovirus/genetics , Enterovirus B, Human/genetics , Public Health
3.
J Infect Dis ; 203(1): 18-24, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-21148492

ABSTRACT

We describe the first confirmed person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus that occurred in a hematology unit in the United Kingdom. Eleven cases of (H1N1) 2009 virus infection were identified, of which, ten were related as shown by sequence analysis of the hemagglutinin and neuraminidase genes. H275Y analysis demonstrated that 8 of 10 case patients had oseltamivir-resistant virus, with 4 of 8 case patients infected by direct transmission of resistant virus. Zanamivir should be considered as first-line therapy for influenza in patients with lymphopenic hematological conditions and uptake of influenza vaccination encouraged to further reduce the number of susceptible individuals.


Subject(s)
Antiviral Agents/pharmacology , Drug Resistance, Viral , Influenza A Virus, H1N1 Subtype/drug effects , Influenza, Human/transmission , Influenza, Human/virology , Oseltamivir/pharmacology , Adult , Aged , Amino Acid Substitution/genetics , Cross Infection/transmission , Cross Infection/virology , Hemagglutinins, Viral/genetics , Hospitals , Humans , Influenza A Virus, H1N1 Subtype/isolation & purification , Lymphopenia/complications , Middle Aged , Mutation, Missense , Neuraminidase/genetics , RNA, Viral/genetics , Sequence Analysis, DNA , United Kingdom , Viral Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...